Effects of local application of 5-hydroxytryptamine into the dorsal or median raphe nuclei on haloperidol-induced catalepsy in the rat

Neuropharmacology

Volumn 38, Issue 1, 1999, Pages 151-156

  Wadenberg, M L G ^a,c   Young, K A ^a,b,c   Richter, J T ^a   Hicks, P B ^a  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^b Veterans Healthcare System   (United States)

^c the Texas AM University System Health Science Center   (United States)

Author keywords

Catalepsy; Dopamine; Dorsal raphe; Median raphe; Rat; Serotonin

Indexed keywords

HALOPERIDOL; SEROTONIN; SEROTONIN AGONIST;

ANIMAL EXPERIMENT; ARTICLE; CATALEPSY; DORSAL RAPHE NUCLEUS; HEAD TWITCH; INTRACEREBRAL DRUG ADMINISTRATION; MALE; MEDIAN RAPHE NUCLEUS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE; WET DOG SHAKES;

ANIMALS; CATALEPSY; DOPAMINE; DOPAMINE ANTAGONISTS; HALOPERIDOL; INJECTIONS, SUBCUTANEOUS; MALE; MONOAMINE OXIDASE INHIBITORS; NEURONS; PHENETHYLAMINES; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SODIUM CHLORIDE;

EID: 0032968780     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00162-2     Document Type: Article

References (35)

1. Ahlenius S., Hillegaart V. Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: a comparison between the effects produced by pre- and postsynaptic inhibition of dopaminergic neurotransmission. Pharmacol. Biochem. Behav. 24:1986;1409-1415.
2. Ames D., Wirshing W.C., Marder S.R., Yuwiler A., Brammer G.L., Midha K.K., Van Putten T. Adjunctive fluoxetine in haloperidol-stabilized schizophrenics. Neuropsychopharmacology. 9:1993;116S.
3. Ask A.-L., Högberg K., Schmidt L., Kiessling H., Ross S.B. 4-Dimethylamino-2,α-dimethylphenethylamine (FLA336(+)), a selective inhibitor of the A form of monoamine oxidase in the rat brain. Biochem. Pharmacol. 31:1982;1401-1406.
4. Azmitia E.C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol. 179:1978;641-668.
5. Balsara J.J., Jadhav J.H., Chandorka A.G. Effects of drugs influencing central serotonergic mechanisms of haloperidol-induced catalepsy. Psychopharmacology. 62:1979;67-69.
6. Choinard G., Sultan S. A case of Parkinson's disease exacerbated by fluoxetine. Human Psychopharmacol. 7:1992;63-66.
7. Dahlström, A., Fuxe, K., 1964. Evidence for the existence of monoamine-containing neurons in the central nervous system; I demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand., suppl. 232 62, 1-55.
8. Elliott P.J., Walsh D.M., Close S.P., Higgins G.A., Hayes A.G. Behavioural effects of serotonin agonists and antagonists in the rat and marmoset. Neuropharmacology. 29:1990;949-956.
9. Fuenmayor L.D., Vogt M. The influence of cerebral 5-hydroxytryptamine on catalepsy induced by brain-amine depleting neuroleptics or by cholinomimetics. Br. J. Pharmacol. 67:1979;309-318.
10. 2 serotonin receptors. J. Med. Chem. 31:1988;5-7.
11. Gumulka W., Kostowsky W., Czlonkowski A. Role of 5-HT in the action of some drugs affecting extrapyramidal system. Pharmacology. 10:1973;363-372.
12. Hicks P.B. The effect of serotonergic agents on haloperidol-induced catalepsy. Life Sci. 47:1990;1609-1615.
13. Hillegaart V. Functional topography of brain serotonergic pathways in the rat. Acta Physiol. Scand. suppl. 598:1991;142.
14. 1A agonist 8-OH-DPAT stimulates rat motor activity. Eur. J. Pharmacol. 160:1989;303-307.
15. Hillegaart V., Hjorth S., Ahlenius S. Effects of 5-HT and 8-OH-DPAT on forebrain monoamine synthesis after local application into the median and dorsal raphe nuclei of the rat. J. Neural Transm. [Gen. Sect.]. 81:1990;131-145.
16. Hollander M., Wolfe D. Nonparametric Statistical Methods. 1973;Wiley and Sons, New York.
17. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. VII International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
18. 1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis. Neuropharmacology. 27:1988;515-518.
19. Janssen-Steur E.N.H. Increase in Parkinson disability after fluoxetine medication. Neurology. 43:1993;211-213.
20. Keppel Hesselink J.M. Exacerbation of Parkinson's disease by fluoxetine. Human Psychopharmacol. 7:1992;411-412.
21. Ketai R. Interaction between fluoxetine and neuroleptics. Am. J. Psychiat. 150:1993;836-837.
22. Kostowsky W., Gumulka W., Czlonkowski A. Reduced cataleptogenic effects of some neuroleptics in rats with lesioned midbrain raphe and treated with p̄-chlorophenylalanine. Brain Res. 48:1972;443-446.
23. Li C.C. Introduction to Experimental Statistics. 1964;McGraw-Hill, New York.
24. 1 sites in the rat brain. Brain Res. 291:1984;159-163.
25. McMillen B., Scott S., Davanzo E. Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs. J. Pharm. Pharmacol. 40:1988;885-887.
26. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;London Academic Press, London.
27. Pazos A., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346:1985;205-230.
28. Radja F., Laporte A.M., Daval G., Vergé D., Gozlan H., Hamon M. Autoradiography of serotonin receptor subtypes in the central nervous system. Neurochem. Int. 18:1991;1-15.
29. Steinbusch H.W.M., Nieuwenhuys R. The raphe nuclei of the rat brain stem: a cytoarchitectonic and immunohistochemical study. Emson P.C. Chemical Neuroanatomy. 1983;131-207 Raven Press, New York.
30. 2 receptors and the wet-dog shakes they mediate, but not frontal cortical β-adrenoceptors. Eur. J. Pharmacol. 294:1995;721-726.
31. Wadenberg M.-L. Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat. Neurosci. Biobehav. Rev. 20:1996;325-339.
32. Wadenberg M.-L., Ahlenius S. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy. J. Neural Transm. 83:1991;43-53.
33. 2A/C receptor agonist DOI of raclopride-induced catalepsy in the rat. Eur. J. Pharmacol. 294:1995;247-251.
34. 1A autoreceptors by local application of 8-OH-DPAT reverses raclopride-induced catalepsy in the rat. Neuropharmacology. 34:1995;495-499.
35. Waldmeier P.C., Delini-Stula A. Serotonin-dopamine interactions in the nigro-striatal system. Eur. J. Pharmacol. 55:1979;363-373.